Veterinary Biologics Market Report 2026
Veterinary Biologics Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Veterinary Biologics Market Report 2026

Global Outlook – By Product (Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products), By Disease Type (Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Disease Types), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels), By Application (Production Animal, Companion Animal) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Veterinary Biologics Market Overview

• Veterinary Biologics market size has reached to $13.61 billion in 2025

• Expected to grow to $20.03 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%

• Growth Driver: Rising Pet Adoption Fuels Surge In Veterinary Biologics Market By Enhancing Pet Health And Well-Being

• Market Trend: Merck Animal Health Launches USDA-Approved Vaccine For Avian Metapneumovirus To Address Poultry Respiratory Issues

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Veterinary Biologics Market?

Veterinary biologics refers to biological products derived from living organisms, such as bacteria, viruses, or other microorganisms. Veterinary biologics are used in veterinary medicine to prevent, diagnose, or treat animal diseases.

The main types of products included in veterinary biologics are vaccines, diagnostic kits, immunomodulators, antiserums and antibodies, and others. Vaccines refer to medical products designed to stimulate the immune system and provide protection against specific diseases. These are used to treat several diseases, including bluetongue, foot and mouth disease, brucellosis and tuberculosis, and others. These are sold through various distribution channels, such as veterinary hospitals, veterinary clinics, and others, for use in several applications, including production animals and companion animals.

Veterinary Biologics market report bar graph

What Is The Veterinary Biologics Market Size and Share 2026?

The veterinary biologics market size has grown strongly in recent years. It will grow from $13.61 billion in 2025 to $14.61 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to growing prevalence of livestock diseases, rise in companion animal population, advancements in vaccine development, increased government funding for veterinary research, expansion of veterinary healthcare infrastructure.

What Is The Veterinary Biologics Market Growth Forecast?

The veterinary biologics market size is expected to see strong growth in the next few years. It will grow to $20.03 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to technological advancements in biologics, increasing adoption of precision medicine in animals, rise in global pet ownership, growing awareness about zoonotic diseases, expansion of veterinary diagnostics market. Major trends in the forecast period include increased focus on preventive animal healthcare, growing adoption of rapid diagnostic solutions, expansion of companion animal biologics, integration of immunomodulators in veterinary treatments, rising demand for livestock disease management solutions.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Veterinary Biologics Market Segmentation

1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products

2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Disease Types

3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels

4) By Application: Production Animal, Companion Animal

Subsegments:

1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines

2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits

3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants

4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums

5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids

What Is The Driver Of The Veterinary Biologics Market?

The increasing adoption of pets is expected to propel the growth of the veterinary biologics market going forward. Pet adoption refers to the process of taking responsibility for a domesticated animal, often from a shelter, or rescue organization, to provide the animal with a permanent and caring home. Adoption of pets is rising due to increased awareness of animal welfare, as more people recognize the benefits of adopting rescued animals and choose adoption over purchasing pets. Veterinary biologics prevent the impact of various infectious diseases in pets, provide immunity, and control of zoonotic diseases, improve lifespan and quality of life, reduce veterinary healthcare costs, enhance reproductive health in pets, and offer more targeted and customized treatment options. For instance, in March 2025, according to the American Pet Products Association, a US-based non-profit association, ninety-four (94) million U.S. households own at least one pet, compared to eighty-two (82) million in 2023. Therefore, the increasing adoption of pets is driving the growth of the veterinary biologics industry.

Key Players In The Global Veterinary Biologics Market

Major companies operating in the veterinary biologics market are Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics, HIPRA, Indian Immunologicals Ltd., Vetoquinol, Beijing SVA Vaccines Serums

Global Veterinary Biologics Market Trends and Insights

Major companies operating in the veterinary biologics market are focusing on developing novel biologics such as vaccines to enhance animal health and disease prevention. A vaccine is a substance that stimulates the immune system to recognize and fight specific pathogens. It helps prevent infectious diseases by providing acquired immunity. For instance, in August 2024, Merck Animal Health, a US-based global animal health company, launched an experimental autogenous vaccine targeting avian metapneumovirus (aMPV) type B, receiving approval from the U.S. Department of Agriculture (USDA) for manufacturing and sale. Developed in collaboration with Cambridge Technologies, this vaccine aims to combat the severe respiratory issues caused by aMPV type B in poultry, which have led to significant economic losses since late 2023. Produced at a state-of-the-art facility in Minnesota, the vaccine features an oil and water emulsion formulation designed to minimize post-vaccination tissue reactions, addressing a critical gap in the market as no commercially licensed vaccines were previously available.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Veterinary Biologics Market?

In January 2024, Ceva Santé Animale, a France-based pharmaceutical company, acquired Scout Bio for an undisclosed amount. This acquisition strengthens Ceva’s biotechnology capabilities and accelerates its innovation in pet therapeutics, with a particular focus on advanced treatments for chronic diseases. The move aligns with the increasing demand for improved health solutions among pet owners. Scout Bio is a a US-based biotechnology company, specializes in providing critical data for developing effective veterinary biologics, such as vaccines and diagnostics.

Regional Outlook

North America was the largest region in the veterinary biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Biologics Market?

The veterinary biologics market consists of sales of transplant tissues, recombinant proteins, and stem cells. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Veterinary Biologics Market Report 2026?

The veterinary biologics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary biologics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Veterinary Biologics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $14.61 billion
Revenue Forecast In 2035 $20.03 billion
Growth Rate CAGR of 7.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Disease Type, Distribution Channel, Application
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics, HIPRA, Indian Immunologicals Ltd., Vetoquinol, Beijing SVA Vaccines Serums
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Veterinary Biologics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Veterinary Biologics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Veterinary Biologics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Veterinary Biologics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Biotechnology, Genomics & Precision Medicine

4.2. Major Trends

4.2.1 Increased Focus On Preventive Animal Healthcare

4.2.2 Growing Adoption Of Rapid Diagnostic Solutions

4.2.3 Expansion Of Companion Animal Biologics

4.2.4 Integration Of Immunomodulators In Veterinary Treatments

4.2.5 Rising Demand For Livestock Disease Management Solutions

5. Veterinary Biologics Market Analysis Of End Use Industries

5.1 Veterinary Hospitals

5.2 Veterinary Clinics

5.3 Livestock Farms

5.4 Research & Diagnostic Laboratories

5.5 Animal Health Organizations

6. Veterinary Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Biologics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Veterinary Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Veterinary Biologics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Veterinary Biologics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Veterinary Biologics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Biologics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Biologics Market Segmentation

9.1. Global Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products

9.2. Global Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Disease Types

9.3. Global Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels

9.4. Global Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Production Animal, Companion Animal

9.5. Global Veterinary Biologics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines

9.6. Global Veterinary Biologics Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits

9.7. Global Veterinary Biologics Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cytokines, Adjuvants, Immunostimulants

9.8. Global Veterinary Biologics Market, Sub-Segmentation Of Antiserums And Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums

9.9. Global Veterinary Biologics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Probiotics, Prebiotics, Growth Factors, Toxoids

10. Veterinary Biologics Market Regional And Country Analysis

10.1. Global Veterinary Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Veterinary Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Biologics Market

11.1. Asia-Pacific Veterinary Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Biologics Market

12.1. China Veterinary Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Biologics Market

13.1. India Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Biologics Market

14.1. Japan Veterinary Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Biologics Market

15.1. Australia Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Biologics Market

16.1. Indonesia Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Biologics Market

17.1. South Korea Veterinary Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Biologics Market

18.1. Taiwan Veterinary Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Biologics Market

19.1. South East Asia Veterinary Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Biologics Market

20.1. Western Europe Veterinary Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Biologics Market

21.1. UK Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Biologics Market

22.1. Germany Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Biologics Market

23.1. France Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Biologics Market

24.1. Italy Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Biologics Market

25.1. Spain Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Biologics Market

26.1. Eastern Europe Veterinary Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Biologics Market

27.1. Russia Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Biologics Market

28.1. North America Veterinary Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Biologics Market

29.1. USA Veterinary Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Biologics Market

30.1. Canada Veterinary Biologics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Biologics Market

31.1. South America Veterinary Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Biologics Market

32.1. Brazil Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Biologics Market

33.1. Middle East Veterinary Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Biologics Market

34.1. Africa Veterinary Biologics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Biologics Market Regulatory and Investment Landscape

36. Veterinary Biologics Market Competitive Landscape And Company Profiles

36.1. Veterinary Biologics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Veterinary Biologics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Veterinary Biologics Market Company Profiles

36.3.1. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Boehringer Ingelheim Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Elanco Animal Health Overview, Products and Services, Strategy and Financial Analysis

36.3.5. IDEXX Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Biologics Market Other Major And Innovative Companies

Virbac SA, Phibro Animal Health Corporation, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics, HIPRA

38. Global Veterinary Biologics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Biologics Market

40. Veterinary Biologics Market High Potential Countries, Segments and Strategies

40.1 Veterinary Biologics Market In 2030 - Countries Offering Most New Opportunities

40.2 Veterinary Biologics Market In 2030 - Segments Offering Most New Opportunities

40.3 Veterinary Biologics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Veterinary Biologics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Veterinary Biologics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Veterinary Biologics Market, Supply Chain Analysis
  • Table 4: Global Veterinary Biologics Market, Major Raw Material Providers
  • Table 5: Global Veterinary Biologics Market, Major Resource Providers
  • Table 6: Global Veterinary Biologics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Veterinary Biologics Market, Major Distributors And Channel Partners
  • Table 8: Global Veterinary Biologics Market, Key Technologies & Future Trends
  • Table 9: Global Veterinary Biologics Market, Major Trends
  • Table 10: Global Veterinary Biologics Market, Major End Users
  • Table 11: Global Veterinary Biologics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Veterinary Biologics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Veterinary Biologics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Veterinary Biologics Market - TAM, US$ Billion, 2025
  • Table 15: Global Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Veterinary Biologics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Veterinary Biologics Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Veterinary Biologics Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Veterinary Biologics Market, Sub-Segmentation Of Antiserums And Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Veterinary Biologics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Veterinary Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Veterinary Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Veterinary Biologics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Veterinary Biologics Market - Company Scoring Matrix
  • Table 100: Zoetis Inc. Financial Performance
  • Table 101: Merck Animal Health Inc. Financial Performance
  • Table 102: Boehringer Ingelheim Animal Health Inc. Financial Performance
  • Table 103: Elanco Animal Health Financial Performance
  • Table 104: IDEXX Laboratories Inc. Financial Performance
  • Table 105: Global Veterinary Biologics Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Veterinary Biologics Market, Competitive Dashboard
  • Table 107: Global Veterinary Biologics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Veterinary Biologics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 109: Global, Veterinary Biologics Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Table 110: Global, Veterinary Biologics Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Veterinary Biologics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Veterinary Biologics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Veterinary Biologics Market, Supply Chain Analysis
  • Figure 4: Global Veterinary Biologics Market, Major Raw Material Providers
  • Figure 5: Global Veterinary Biologics Market, Major Resource Providers
  • Figure 6: Global Veterinary Biologics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Veterinary Biologics Market, Major Distributors And Channel Partners
  • Figure 8: Global Veterinary Biologics Market, Key Technologies & Future Trends
  • Figure 9: Global Veterinary Biologics Market, Major Trends
  • Figure 10: Global Veterinary Biologics Market, Major End Users
  • Figure 11: Global Veterinary Biologics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Veterinary Biologics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Veterinary Biologics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Veterinary Biologics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Veterinary Biologics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Veterinary Biologics Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Veterinary Biologics Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Veterinary Biologics Market, Sub-Segmentation Of Antiserums And Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Veterinary Biologics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Veterinary Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Veterinary Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Veterinary Biologics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Veterinary Biologics Market - Company Scoring Matrix
  • Figure 100: Zoetis Inc. Financial Performance
  • Figure 101: Merck Animal Health Inc. Financial Performance
  • Figure 102: Boehringer Ingelheim Animal Health Inc. Financial Performance
  • Figure 103: Elanco Animal Health Financial Performance
  • Figure 104: IDEXX Laboratories Inc. Financial Performance
  • Figure 105: Global Veterinary Biologics Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Veterinary Biologics Market, Competitive Dashboard
  • Figure 107: Global Veterinary Biologics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Veterinary Biologics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 109: Global, Veterinary Biologics Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Figure 110: Global, Veterinary Biologics Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Frequently Asked Questions

The Veterinary Biologics market was valued at $13.61 billion in 2025, increased to $13.61 billion in 2026, and is projected to reach $20.03 billion by 2030. request a sample here

The expected CAGR for the Veterinary Biologics market during the forecast period 2025–2030 is 8.2%. request a sample here

Major growth driver of the market includes: The increasing adoption of pets is expected to propel the growth of the veterinary biologics market going forward. Pet adoption refers to the process of taking responsibility for a domesticated animal, often from a shelter, or rescue organization, to provide the animal with a permanent and caring home. Adoption of pets is rising due to increased awareness of animal welfare, as more people recognize the benefits of adopting rescued animals and choose adoption over purchasing pets. Veterinary biologics prevent the impact of various infectious diseases in pets, provide immunity, and control of zoonotic diseases, improve lifespan and quality of life, reduce veterinary healthcare costs, enhance reproductive health in pets, and offer more targeted and customized treatment options. For instance, in March 2025, according to the American Pet Products Association, a US-based non-profit association, ninety-four (94) million U.S. households own at least one pet, compared to eighty-two (82) million in 2023. Therefore, the increasing adoption of pets is driving the growth of the veterinary biologics market. in the Veterinary Biologics market. For further insights on this market, request a sample here

The veterinary biologics market covered in this report is segmented –
1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products
2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Disease Types
3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels
4) By Application: Production Animal, Companion Animal Subsegments:
1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines
2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits
3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants
4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums
5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids
request a sample here

Major trend in this market includes: Merck Animal Health Launches USDA-Approved Vaccine For Avian Metapneumovirus To Address Poultry Respiratory Issues For further insights on this market, request a sample here.

Major companies operating in the Veterinary Biologics market are Major companies operating in the veterinary biologics market are Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics, HIPRA, Indian Immunologicals Ltd., Vetoquinol, Beijing SVA Vaccines Serums request a sample here.

North America was the largest region in the veterinary biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts